Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: A descriptive study

被引:66
作者
Irfan, Seema [1 ]
Idrees, Faiza [1 ]
Mehraj, Vikram [1 ]
Habib, Faizah [1 ]
Adil, Salman [1 ]
Hasan, Rumina [1 ]
机构
[1] Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan
关键词
D O I
10.1186/1471-2334-8-80
中图分类号
R51 [传染病];
学科分类号
100401 [流行病与卫生统计学];
摘要
Background: This study was conducted to evaluate drug resistance amongst bacteremic isolates of febrile neutropenic patients with particular emphasis on emergence of carbapenem resistant Gram negative bacteria and vancomycin resistant Enterococcus species. Methods: A descriptive study was performed by reviewing the blood culture reports from febrile neutropenic patients during the two study periods i. e., 1999 - 00 and 2001 - 06. Blood cultures were performed using BACTEC 9240 automated system. Isolates were identified and antibiotic sensitivities were done using standard microbiological procedures. Results: Seven twenty six febrile neutropenic patients were admitted during the study period. A total of 5840 blood cultures were received, off these 1048 (18%) were culture positive. Amongst these, 557 (53%) grew Gram positive bacteria, 442 ( 42%) grew Gram negative bacteria, 43 (4%) fungi and 6 (1%) anaerobes. Sixty ( 5.7%) out of 1048 positive blood cultures were polymicrobial. In the Gram negative bacteria, Enterobacteriaceae was the predominant group; E. coli was the most frequently isolated organism in both study periods. Amongst non-Enterobacteriaceae group, Pseudomonas aeruginosa was the commonest organism isolated during first study period followed by Acinetobacter spp. However, during the second period Acinetobacter species was the most frequent pathogen. Enterobacteriaceae group showed higher statistically significant resistance in the second study period against ceftriaxone, quinolone and piperacillin/tazobactam, whilst no resistance observed against imipenem/meropenem. The susceptibility pattern of Acinetobacter species shifted from sensitive to highly resistant one with significant p values against ceftriaxone, quinolone, piperacillin/ tazobactam and imipenem/meropenem. Amongst Gram positive bacteria, MRSA isolation rate remained static, vancomycin resistant Enterococcus species emerged in second study period while no Staphylococcus species resistant to vancomycin was noted. Conclusion: This rising trend of highly resistant organisms stresses the increasing importance of continuous surveillance system and stewardship of antibiotics as strategies in the overall management of patients with febrile neutropenia.
引用
收藏
页数:6
相关论文
共 23 条
[1]
Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia [J].
Baskaran, Nirmala Devi ;
Gan, Gin Gin ;
Adeeba, Kamarulzaman ;
Sam, I-Ching .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (06) :513-517
[2]
Burney Ikram A., 1998, JPMA (Journal of the Pakistan Medical Association), V48, P364
[3]
Chen CY, 2004, J FORMOS MED ASSOC, V103, P526
[4]
Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study [J].
El-Mahallawy, H ;
Sidhom, I ;
El-Din, NHA ;
Zamzam, M ;
El-Lamie, MM .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2005, 9 (01) :43-51
[5]
Vancomycin as part of initial empirical antibiotic therapy for febrile neutropenia in patients with cancer: Pros and cons [J].
Feld, R .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (03) :503-507
[6]
Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients:: Geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999) [J].
Gales, AC ;
Jones, RN ;
Forward, KR ;
Liñares, J ;
Sader, HS ;
Verhoef, J .
CLINICAL INFECTIOUS DISEASES, 2001, 32 :S104-S113
[7]
An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients [J].
Glasmacher, A ;
von Lilienfeld-Toal, M ;
Schulte, S ;
Hahn, C ;
Schmidt-Wolf, IGH ;
Prentice, A .
CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 :17-23
[8]
Clinical and bacteriological characteristics of IMP-type metallo-β-lactamase-producing Pseudomonas aeruginosa [J].
Hirakata, Y ;
Yamaguchi, T ;
Nakano, M ;
Izumikawa, K ;
Mine, M ;
Aoki, S ;
Kondoh, A ;
Matsuda, J ;
Hirayama, M ;
Yanagihara, K ;
Miyazaki, Y ;
Tomono, K ;
Yamada, Y ;
Kamihira, S ;
Kohno, S .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (01) :26-32
[9]
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer [J].
Hughes, WT ;
Armstrong, D ;
Bodey, GP ;
Bow, EJ ;
Brown, AE ;
Calandra, T ;
Feld, R ;
Pizzo, PA ;
Rolston, KVI ;
Shenep, JL ;
Young, LS .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (06) :730-751
[10]
Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia [J].
Jones, RN .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (03) :495-502